TARIL Commits Rs 1,250 Crore to Three Manufacturing Plants
TARIL is planning an investment of Rs 1,250 crore to set up three manufacturing plants in India, as reported by Sahi on 27 October 2026. No further details on the locations, product lines or timeline of these facilities were available at the time of reporting.
| Detail | Information |
|---|---|
| Promoter / Investor | TARIL |
| Number of Plants | 3 |
| Total Investment | Rs 1,250 crore |
| Sector | Drugs & Pharmaceuticals (Industrial Projects) |
| Country | India |
| Reported On | 27 October 2026 |
Context: India's Pharmaceuticals Project Pipeline
The TARIL announcement sits within a large and active project pipeline. Projects India tracks 1,795 live projects in the drugs and pharmaceuticals sub-sector, with 14 new projects added in the last 90 days alone. Of these, 637 are currently under approvals, 362 are at the construction-started stage, and 137 have received approvals and are awaiting the next step. A further 98 are at the planning stage, indicating a steady pipeline of work likely to come to market in the near term.
Suppliers and contractors active in this sector will find projects spread across multiple stages simultaneously, meaning opportunities exist both for early-stage advisory and tendering as well as for active construction and fit-out contracts.
Where Pharma Projects Are Concentrated
Gujarat leads all states in drugs and pharmaceuticals project activity tracked by Projects India, with 607 projects on record. Telangana follows with 244, Andhra Pradesh with 231, Karnataka with 215, Maharashtra with 167 and Himachal Pradesh with 59. This distribution reflects the established pharmaceutical manufacturing clusters around Ahmedabad, Hyderabad and Bengaluru, as well as the presence of special economic zones and bulk drug parks in these states.
Recent projects entering the pipeline illustrate the geographic spread. These include an API and intermediates project in Palghar, Maharashtra, where construction has already started; a bulk drugs manufacturing unit at Pithampur in Madhya Pradesh currently under approvals; a pharmaceutical project at Verna in South Goa where construction has commenced; and an API manufacturing facility at Tirunelveli in Tamil Nadu at the approvals stage. The range of project sizes — from Rs 7 crore to Rs 195 crore across recently tracked entries — shows that activity is not confined to large-ticket investments.
Recent Notable Pharma Investment Decisions
TARIL's planned outlay of Rs 1,250 crore is among the larger single-company commitments reported in the sector in recent months. Other recent capital decisions tracked in the broader sector include an Rs 81 crore commitment by an SJS Enterprises subsidiary for a Pune pharmaceutical facility. Separately, Kilitch Drugs has reported plans to divest an overseas pharmaceutical plant, reflecting the varied strategic directions companies in this sector are pursuing.
What this means for suppliers and contractors
A three-plant programme of Rs 1,250 crore represents a substantial procurement opportunity across civil construction, process equipment, utilities, cleanroom fitout, HVAC and validation services. Because no locations have been confirmed in available reporting, suppliers cannot yet target a specific region, but those already active across Gujarat, Telangana, Andhra Pradesh and Karnataka — the states where pharma project density is highest — are best positioned to respond when site details emerge.
The broader pipeline context reinforces the opportunity. With 637 projects under approvals and 98 at the planning stage nationally, the industrial projects sector is generating a continuous flow of tender-ready work. Contractors and equipment makers tracking this sub-sector should monitor TARIL's project disclosures closely as further details on plant locations and scope are confirmed. The stage breakdown also suggests that a meaningful volume of projects currently under approvals will move to construction in coming months, creating additional demand for civil and mechanical contractors.
- 637 drugs and pharmaceuticals projects currently under approvals nationally
- 362 at construction-started stage — active procurement likely
- 98 at planning stage — early engagement opportunities
- Gujarat leads with 607 tracked projects; Telangana and Andhra Pradesh follow
Frequently asked questions
How much is TARIL investing in manufacturing plants in India?
TARIL is planning an investment of Rs 1,250 crore across three manufacturing plants in India, as reported by Sahi on 27 October 2026. No further details on locations or product lines were available in the reporting.
How many pharmaceutical projects are currently tracked in India?
Projects India tracks 1,795 live projects in the drugs and pharmaceuticals sub-sector. Of these, 637 are under approvals, 362 are at construction stage, and 98 are at the planning stage, with 14 new projects added in the last 90 days.
Which states have the most pharmaceutical manufacturing projects in India?
Based on Projects India data, Gujarat leads with 607 tracked drugs and pharmaceuticals projects, followed by Telangana with 244, Andhra Pradesh with 231, Karnataka with 215, Maharashtra with 167 and Himachal Pradesh with 59.
